MWMarc Ronald Wilkins

Marc Ronald Wilkins

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marc Ronald Wilkins has a total of 491 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Research Implications of Genomics in Personalised Primary Care

    by Braulio Mark Valencia, Jialing Lin, Chris Dietz, Peter Brown, Rafal Chomik, Shona Bates, Patricia Mary Davidson, Marc R Wilkins, Michael Kidd

  • Open Access

    Integrative multiomic analysis reveals co-ordinated alternative splicing in human bone marrow stromal stem cells

    by Angelita Liang, Gene Hart-Smith, Moustapha Kassem, Abbas Jafari, Marc R. Wilkins

    Alternative splicing is essential for the production of diverse messenger RNAs from a single gene. However our understanding of alternative splicing and its regulation during processes such as osteoblast differentiation remains incomplete. Using differentiating hMSC-TERT4 cells as a model, we performed deep short- and long-read RNA sequencing, revealing a highly integrated multiphasic differentiation program. Analysis for splicing revealed extensive changes during lineage commitment, in genes associated with known transcriptional regulators including RUNX2, TEAD1, CTNNB1 and NFATC4. During late-stage matrix osteoblast differentiation (maturation), splicing changes occurred in genes encoding cytoskeletal and extracellular matrix proteins, and Golgi and vesicle trafficking proteins. Analysis of proteomic and phosphoproteomic profiles confirmed the presence of alternative splicing in proteins participating in these biological processes as well as in RNA splicing and autophagy, with splicing involving a variety of protein domains, regions and PTM sites. Together, the transcriptomic and protein splicing landscapes provide a comprehensive description of how mesenchymal stromal cells progressively acquire an osteoblastic phenotype.

  • Offline Two-Stage SEC and LC-MS/MS for Comprehensive Characterization of Yeast Ribosomal Populations

    by Andrew J. Spiteri, Joshua J. Hamey, Marc R. Wilkins

    We report two-dimensional size exclusion chromatography tandem mass spectrometry (2D-SEC MS/MS), a workflow that couples two MS-compatible size exclusion chromatography steps to bottom-up proteomics for rapid, high-resolution characterization of Saccharomyces cerevisiae ribosomes. Building on the established Ribo Mega-SEC protocol, we show that a size exclusion chromatography (SEC) run on a 1000 Å column separates intact polysomes from mixed 80S/60S/40S particles, while a reinjection of the pooled 80S/60S/40S peak onto a second-dimension, 500 Å SEC column yields resolved monosome, 60S, and 40S subunit fractions. This method is thereby able to deliver four distinct ribosomal subpopulations in RPL7A knockout, we show that 2D-SEC MS/MS detects rapid polysome collapse and changes to the polysome profiling ratios, illustrating its capacity to link ribosome composition to functional perturbations.

  • Open Access

    Congenital Titinopathy: Comprehensive Characterization of the Most Severe End of the Disease Spectrum

    by Sandra Coppens, Nicolas Deconinck, Patricia Sullivan, Andrei Smolnikov, Joshua S. Clayton, Kaitlyn R. Griffin, Kristi J. Jones, Catheline N. Vilain, Hazim Kadhim, Samantha J. Bryen, et al.

    Congenital titinopathy has recently emerged as one of the most common congenital muscle disorders.Objective: To better understand the presentation and clinical needs of the under‐characterized extreme end of the congenital titinopathy severity spectrum.Methods: We comprehensively analyzed the clinical, imaging, pathology, autopsy, and genetic findings in 15 severely affected individuals from 11 families.Results: Prenatal features included hypokinesia or akinesia and growth restriction. Six pregnancies were terminated. Nine infants were born at or near term with severe‐to‐profound weakness and required resuscitation. Seven died following withdrawal of life support. Two surviving children require ongoing respiratory support. Most cohort members had at least 1 disease‐causing variant predicted to result in some near‐normal‐length titin expression. The exceptions, from 2 unrelated families, had homozygous truncating variants predicted to induce complete nonsense mediated decay. However, subsequent analyses suggested that the causative variant in each family had an additional previously unrecognized impact on splicing likely to result in some near‐normal‐length titin expression. This impact was confirmed by minigene assay for 1 variant.Interpretation: This study confirms the clinical variability of congenital titinopathy. Severely affected individuals succumb prenatally/during infancy, whereas others survive into adulthood. It is likely that this variability is because of differences in the amount and/or length of expressed titin. If confirmed, analysis of titin expression could facilitate clinical prediction and increasing expression might be an effective treatment strategy. Our findings also further‐support the hypothesis that some near‐normal‐length titin expression is essential to early prenatal survival. Sometimes expression of normal/near‐normal‐length titin is due to disease‐causing variants having an additional impact on splicing. ANN NEUROL 2025;97:611–628


  • Open Access

    Alternative splicing in 300 human cells and tissues is sparsely distributed and strongly associated with cell identity

    by Angelita Liang, Marc R Wilkins

    In eukaryotes, alternative splicing allows RNA sequences to be changed as required in their cellular context. While the use of gene expression without considering transcript isoforms is commonly used to classify cell types, the significance of alternative splicing to cell identity is not fully understood. Using data-driven classification and clustering methods, we analysed the RNA Atlas, an ultra-deep total RNA and polyA capture sequencing dataset obtained from 300 different types of cell and tissue samples across the human body. We show that splice inclusion values can distinguish cell identity effectively, and sometimes better than gene expression. These specific differences in alternative splicing are biologically relevant, with many splice events expressed in a limited number of cell types. We show that distributions of splice inclusion levels are “sparser” than gene expression levels, being discontinuous and containing outliers – akin to a control dial with a few settings. Gene expression levels display finer variation, taking on a diverse range of values akin to a control dial with many increments. Complementary analysis of comparable RNA-Seq samples from the ENCODE dataset yielded consistent results regardless of the splice event or gene expression quantification tools used, as well as the choice of RiboMinus TM or polyA capture-derived RNA libraries. Our results highlight the utility of alternative splicing data in data-driven and functional analyses, and the unique relationship between alternative splicing and cell identity.

  • Open Access

    Penicillium psychrofluorescens sp. nov., a naturally autofluorescent Antarctic fungus

    by Alinta Furnell, Nicole Benaud, Xabier Vázquez-Campos, Edward C.Y. Liew, Allison Mertin, Jordan A. Vink, Kate Montgomery, Marc R. Wilkins, Brett A. Summerell, Belinda C. Ferrari

    A new fungal species, Penicillium psychrofluorescens sp. nov. is described as a member of section Torulomyces. The new species is sister to P. catalonicum, and was isolated from soil collected from Robinson Ridge, East Antarctica, following enrichment cultivation under oligotrophic conditions supplemented with excess hydrogen gas. Penicillium psychrofluorescens is named for its intense autofluorescence derived from a combination of compounds that may include NADPH, porphyrins, and secondary metabolites, such as polyketides. Comparative genomics with both Antarctic and mesophilic Penicillium spp. shows that Penicillium psychrofluorescens has a wide repertoire of glycoside hydrolases, but almost no polysaccharide lyases, has comparably large effector proteins, lacks the machinery to use nitrate as an N-source, but has the genes for the assimilation of phosphorus from phosphonates via oxidative pathway. The strain was found to have 30 biosynthetic gene clusters (BGCs), the majority of which were unrelated to known compound BGCs. Given the remarkable diversity of natural products already characterised from Penicillium spp. and the presence of >30 BGCs with low similarity to known genes, there is biotechnological potential within this novel species that is yet to be explored.


  • Open Access

    Inferring gene regulatory networks by hypergraph variational autoencoder

    by Guangxin Su, Hanchen Wang, Ying Zhang, Adelle Cf Coster, Marc R. Wilkins, Pablo F. Canete, Di Yu, Yang Yang, Wenjie Zhang

    In constructing Gene Regulatory Networks (GRNs), it is crucial to consider cellular heterogeneity and differential gene regulatory modules. However, traditional methods have predominantly focused on cellular heterogeneity, approaching the subject from a relatively narrow scope. We present HyperG-VAE, a Bayesian deep generative model that utilizes a hypergraph to model single-cell RNA sequencing (scRNA-seq) data. HyperG-VAE employs a cell encoder with a Structural Equation Model to address cellular heterogeneity and build GRNs, alongside a gene encoder using hypergraph self-attention to identify gene modules. Encoders are synergistically optimized by a decoder, enabling HyperG-VAE to excel in GRN inference, single-cell clustering, and data visualization, evidenced by benchmarks. Additionally, HyperG-VAE effectively reveals gene regulation patterns and shows robustness in varied downstream analyses, demonstrated using B cell development data in bone marrow. The interplay of encoders by the overlapping genes between predicted GRNs and gene modules is further validated by gene set enrichment analysis, underscoring that the gene encoder boosts the GRN inference. HyperG-VAE proves efficient in scRNA-seq data analysis and GRN inference.


  • ApoA-I Protects Pancreatic β-Cells From Cholesterol-Induced Mitochondrial Damage and Restores Their Ability to Secrete Insulin

    by Bikash Manandhar, Elvis Pandzic, Nandan Deshpande, Sing-Young Chen, Valerie C. Wasinger, Maaike Kockx, Elias N. Glaros, Kwok Leung Ong, Shane R. Thomas, Marc R. Wilkins, et al.

    BACKGROUND: High cholesterol levels in pancreatic β-cells cause oxidative stress and decrease insulin secretion. β-cells can internalize apo (apolipoprotein) A-I, which increases insulin secretion. This study asks whether internalization of apoA-I improves β-cell insulin secretion by reducing oxidative stress. METHODS: Ins-1E cells were cholesterol-loaded by incubation with cholesterol-methyl-β-cyclodextrin. Insulin secretion in the presence of 2.8 or 25 mmol/L glucose was quantified by radioimmunoassay. Internalization of fluorescently labeled apoA-I by β-cells was monitored by flow cytometry. The effects of apoA-I internalization on β-cell gene expression were evaluated by RNA sequencing. ApoA-I-binding partners on the β-cell surface were identified by mass spectrometry. Mitochondrial oxidative stress was quantified in β-cells and isolated islets with MitoSOX and confocal microscopy. RESULTS: An F 1 -ATPase β-subunit on the β-cell surface was identified as the main apoA-I-binding partner. β-cell internalization of apoA-I was time-, concentration-, temperature-, cholesterol-, and F 1 -ATPase β-subunit-dependent. β-cells with internalized apoA-I (apoA-I + cells) had higher cholesterol and cell surface F 1 -ATPase β-subunit levels than β-cells without internalized apoA-I (apoA-I − cells). The internalized apoA-I colocalized with mitochondria and was associated with reduced oxidative stress and increased insulin secretion. The IF 1 (ATPase inhibitory factor 1) attenuated apoA-I internalization and increased oxidative stress in Ins-1E β-cells and isolated mouse islets. Differentially expressed genes in apoA-I + and apoA-I − Ins-1E cells were related to protein synthesis, the unfolded protein response, insulin secretion, and mitochondrial function. CONCLUSIONS: These results establish that β-cells are functionally heterogeneous, and apoA-I restores insulin secretion in β-cells with elevated cholesterol levels by improving mitochondrial redox balance.


  • Open Access

    Proline‐directed yeast and human MAP kinases phosphorylate the Dot1p/DOT1L histone H3K79 methyltransferase

    by Ryan J. Separovich, Nicola M. Karakatsanis, Kelley Gao, David Fuh, Joshua J. Hamey, Marc R. Wilkins

    Disruptor of telomeric silencing 1 (Dot1p) is an exquisitely conserved histone methyltransferase and is the sole enzyme responsible for H3K79 methylation in the budding yeast Saccharomyces cerevisiae. It has been shown to be highly phosphorylated in vivo; however, the upstream kinases that act on Dot1p are almost entirely unknown in yeast and all other eukaryotes. Here, we used in vitro and in vivo kinase discovery approaches to show that mitogen‐activated protein kinase HOG1 (Hog1p) is a bona fide kinase of the Dot1p methyltransferase. In vitro kinase assays showed that Hog1p phosphorylates Dot1p at multiple sites, including at several proline‐adjacent sites that are consistent with known Hog1p substrate preferences. The activity of Hog1p was specifically enhanced at these proline‐adjacent sites on Dot1p upon Hog1p activation by the osmostress‐responsive MAP kinase kinase PBS2 (Pbs2p). Genomic deletion of HOG1 reduced phosphorylation at specific sites on Dot1p in vivo, providing further evidence for Hog1p kinase activity on Dot1p in budding yeast cells. Phenotypic analysis of knockout and phosphosite mutant yeast strains revealed the importance of Hog1p‐catalysed phosphorylation of Dot1p for cellular responses to ultraviolet‐induced DNA damage. In mammalian systems, this kinase–substrate relationship was found to be conserved: human DOT1L (the ortholog of yeast Dot1p) can be phosphorylated by the proline‐directed kinase p38β (also known as MAPK11; the ortholog of yeast Hog1p) at multiple sites in vitro. Taken together, our findings establish Hog1p and p38β as newly identified upstream kinases of the Dot1p/DOT1L H3K79 methyltransferase enzymes in eukaryotes.